Vaccine News and Research

Latest Vaccine News and Research

Optimal monoclonal antibodies against SARS-CoV-2 variants

Optimal monoclonal antibodies against SARS-CoV-2 variants

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

Unrelated vaccines could also help reduce the burden of COVID-19 pandemic, study shows

Unrelated vaccines could also help reduce the burden of COVID-19 pandemic, study shows

A study on COVID vaccinated vs. unvaccinated that required hospitalization

A study on COVID vaccinated vs. unvaccinated that required hospitalization

Why the French "passe sanitaire" did nothing to solve COVID vaccine inequalities

Why the French "passe sanitaire" did nothing to solve COVID vaccine inequalities

Isolated antibodies from BNT162b2 vacinee effective against Omicron variant

Isolated antibodies from BNT162b2 vacinee effective against Omicron variant

CDC shortens the interval for Moderna booster to 5 months

CDC shortens the interval for Moderna booster to 5 months

FQHCs have played a key role in enabling COVID-19 vaccine equity among people of color

FQHCs have played a key role in enabling COVID-19 vaccine equity among people of color

Hybrid immunity shown to offer sub-optimal protection against SARS-CoV-2 Omicron variant

Hybrid immunity shown to offer sub-optimal protection against SARS-CoV-2 Omicron variant

SARS-CoV-2 viral mutations shown to have a limited effect on T cell immunity

SARS-CoV-2 viral mutations shown to have a limited effect on T cell immunity

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

Neutralization of SARS-CoV-2 variants by three-dose mRNA vaccinated kidney transplant recipient sera

Neutralization of SARS-CoV-2 variants by three-dose mRNA vaccinated kidney transplant recipient sera

Mathematical modeling the vaccination of children against SARS-CoV-2

Mathematical modeling the vaccination of children against SARS-CoV-2

Durability of vaccine protection against COVID-19 breakthrough infections and hospitalizations

Durability of vaccine protection against COVID-19 breakthrough infections and hospitalizations

Humoral and cellular response to primary and booster COVID-19 vaccination in immunosuppressed patients

Humoral and cellular response to primary and booster COVID-19 vaccination in immunosuppressed patients

New molecule offers effective protection against coronavirus for at least eight hours

New molecule offers effective protection against coronavirus for at least eight hours

SARS-CoV-2 Omicron variant's infectivity, vaccine breakthrough, and antibody resistance

SARS-CoV-2 Omicron variant's infectivity, vaccine breakthrough, and antibody resistance

SARS-CoV-2 omicron variant predicted to cause fewer deaths in Florida

SARS-CoV-2 omicron variant predicted to cause fewer deaths in Florida

Declining effectiveness of the BNT162b2 vaccine in adolescents infected with COVID-19

Declining effectiveness of the BNT162b2 vaccine in adolescents infected with COVID-19

Association of vaccination status with Long COVID symptoms

Association of vaccination status with Long COVID symptoms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.